Who Paid My Doc
Collagenase Santyl
Drug Pharma Products
NDC 50484-010-30
General payments
$2,569,867
Research payments
$43,784
Through program year 2025, $2,569,867 in general payments and $43,784 in research payments were reported against Collagenase Santyl (Pharma Products).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $751,142 | 15,441 |
| 2024 | General | $522,826 | 14,359 |
| 2023 | General | $563,295 | 14,898 |
| 2023 | Research | $43,784 | 2 |
| 2022 | General | $713,573 | 17,757 |
| 2021 | General | $19,030 | 2 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 131 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
62,457 general · 2 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.